AmyAI Diagnostics

Detect early, think clearly.

Learn More

Innovation Pipeline

Developing precision, POC device for early Alzheimer's detection.

Nanostructured Architecture

Close-up of a sleek electrochemical biosensor device with glowing purple accents.

Engineering advanced, nanostructure-modified carbon electrodes to provide the ultra-sensitive electrochemical foundation required for rapid point-of-care diagnostics.

Precision Aptamer Technology

Our platform utilizes highly specific, customized aptamers to capture the Alzheimer's biomarkers, ensuring exceptionally precise early neurological detection.

We are actively collaborating with leading European facilities to accelerate the transition from laboratory research to clinical deployment.

Collaborative Prototyping

About AmyAI Diagnostics

We’re in the prototyping phase, validating nanostructured carbon electrodes and DNA aptamers in an electrochemical biosensor designed to sensitively detect Alzheimer biomarkers.

Close-up of a sleek electrochemical biosensor device with glowing indicators on a navy blue background.

Our Mission

Our Approach

AmyAI is building an affordable, point-of-care test to detect Alzheimer’s early through a simple blood sample, bringing advanced neurological screening directly to patients, wherever they are.

Join the Mission

Help us bring early Alzheimer’s detection to reality. Stay connected, support the work, and be part of the journey.

Our Location

Bridging advanced European research infrastructure with strategic innovation to advance the future of neuro-diagnostics.

Address

Istanbul, Turkey

Hours

Mon-Fri 9-6

Contact

info@amyaidiagonstics.com